0001127602-24-001286.txt : 20240112 0001127602-24-001286.hdr.sgml : 20240112 20240112172040 ACCESSION NUMBER: 0001127602-24-001286 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240112 FILED AS OF DATE: 20240112 DATE AS OF CHANGE: 20240112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HENDERSON JOHN T CENTRAL INDEX KEY: 0001226488 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50633 FILM NUMBER: 24532905 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943291317 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 OYSTER POINT BOULEVARD STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 350 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-01-12 0001061983 CYTOKINETICS INC CYTK 0001226488 HENDERSON JOHN T 350 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 1 1 Common Stock 83 I by Spouse Common Stock 2024-01-12 4 M 0 5000 4.44 A 47632 D Common Stock 2024-01-12 4 S 0 5000 85.14 D 42632 D Non-Qualified Stock Option (Right to Buy) 4.44 2024-01-12 4 M 0 5000 0 D 2014-06-21 2024-05-21 Common Stock 5000 5000 D Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023. /s/ John Faurescu, attorney-in-fact for Dr. Henderson 2024-01-12